Predictive value of D-Dimer and thromboplastin time as coagulation indicators for COVID-19 patients
The Journal of Infection in Developing Countries · 2024
DOI: 10.3855/jidc.18593 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infection in Developing Countries, 2024. Verfasst von Marwan Alshipli und 9 weiteren Autor:innen. Beteiligte Einrichtung: Medical Imaging and Radiography Department, Aqaba University of Technology, Aqaba, Jordan. Hauptthemen laut MEDLINE: COVID-19, Fibrin Fibrinogen Degradation Products, Blood Coagulation Disorders, Predictive Value of Tests. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Coronavirus 2019 symptoms include coagulopathy and thromboembolic risk. Using one parameter to diagnose coagulopathy has little predictive value.
Objective
This study will examine if D-dimer and APTT testing can predict COVID-19 severity and aid triage and manage patients.
Methods
214 COVID-19 patients were enrolled and classified into two categories based on their respiratory manifestations; mild (126 cases) and severe (88 cases). Patient data regarding age, gender, D-Dimer level, and APTT level were collected. When both D-Dimer and APTT levels were abnormal, in this study, the patient was considered to have a coagulation disorder. Indicators of coagulation in the COVID-19 patients were collected and compared between the two groups. Chi-square (χ2) tests were used to determine the significant differences between coagulation disorders in the two groups.
Results
Our findings showed that patients with coagulopathies were more likely to belong to the severe group. Within the two groups of patients, the rate of coagulation disorders was as follows: mild = 8.8 % within coagulation disorders, 4.8% within the two Groups; severe = 91.2 % within coagulation disorders, 77.8 % within the two Groups. There was a statistically significant relationship between coagulation disorder and severe COVID-19 patients compared to mild patients (p < 0.05).
Conclusions
Coagulation disorders are more likely to occur in severe COVID-19 patients. D-Dimer and APTT tests are significant indicators for predicting COVID-19 severity. Our research found an abnormal pattern of coagulation disorders and COVID-19 severity that should be considered in the COVID-19 treatment protocol.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Imaging and Radiography Department, Aqaba University of Technology, Aqaba, Jordan.
- Department of Physical Therapy, Faculty of Allied Medical Sciences, Al-Ahliyya Amman University, Jordan.
- Department of Medical Imaging, Faculty of Applied Medical Sciences, The Hashemite University, Zarqa, Jordan.
- Department of Community Health Nursing, College of Nursing, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
- Department of Radiology, the Second Hospital of Jilin University, Changchun, China.
- Department of Pathology, Microbiology and Forensic Medicine, School of Medicine, The University of Jordan, Amman, Jordan.
Zitieren
APA
Alshipli, M., Altaim, T. A., Oglat, A. A., Ahmed Alsenany, S., Khodrog, O., Hasan, H., Mohammed Farghaly Abdelaliem, S., Matrieh, A., Shakhreet, B. Z., & Gaowgzeh, R. A. (2024). Predictive value of D-Dimer and thromboplastin time as coagulation indicators for COVID-19 patients. The Journal of Infection in Developing Countries. https://doi.org/10.3855/jidc.18593
Vancouver
Alshipli M, Altaim TA, Oglat AA, Ahmed Alsenany S, Khodrog O, Hasan H, et al. Predictive value of D-Dimer and thromboplastin time as coagulation indicators for COVID-19 patients. The Journal of Infection in Developing Countries. 2024. doi:10.3855/jidc.18593
BibTeX
@article{Alshipli2024,
author = {Alshipli, Marwan and Altaim, Thamer A and Oglat, Ammar A and Ahmed Alsenany, Samira and Khodrog, Osama and Hasan, Hanan and Mohammed Farghaly Abdelaliem, Sally and Matrieh, A and Shakhreet, Bassam Z and Gaowgzeh, Riziq Allah},
title = {Predictive value of D-Dimer and thromboplastin time as coagulation indicators for COVID-19 patients},
journal = {The Journal of Infection in Developing Countries},
year = {2024},
doi = {10.3855/jidc.18593}
}
EUVIMED